Skip to main content
SpringerLink
Log in

Diagnosis, Prevention, and Management of Venous Thromboembolism in the Adolescent Female

  • Chapter
  • First Online:
Hematology in the Adolescent Female

  • 452 Accesses

Abstract

Venous thromboembolism (VTE) has a bimodal distribution in the pediatric population and most frequently occurs in neonates and adolescents. Adolescent females have unique risk factors for venous thromboembolism which often occurs in the extremities, lungs, and cerebral sinus venous system in these patients. Diagnosis and evaluation of venous thromboembolism in adolescent females depends on the clinical presentation and location of clot. Treatment typically involves anticoagulation and long-term sequelae include recurrent thrombosis and post-thrombotic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Radulescu VC. Management of venous thrombosis in the pediatric patient. Pediatric Health Med Ther. 2015;6:111–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Betensky M, Bittles MA, Colombani (Monagle), et al. How we manage pediatric deep venous thrombosis. Semin Intervent Radiol. 2017;34:35–49.

    PubMed  PubMed Central  Google Scholar 

  3. Jaffray J, Young G. Deep vein thrombosis in pediatric patients. Pediatr Blood Cancer. 2017;65:e26881.

    Google Scholar 

  4. Beyer-Westendorf J. Controversies in venous thromboembolism: to treat or not to treat superficial venous thrombosis. Hematology Am Soc Hematol Educ Program. 2017;1:223–30.

    Google Scholar 

  5. Scott G, Mahdi AJ, Alikhan R. Superficial vein thrombosis: a current approach to management. Br Jr Hematol. 2015;168:639–45.

    CAS  Google Scholar 

  6. Carpenter SL, Richardson T, Hall M. Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014. Blood Adv. 2018;2:1403–8.

    PubMed  PubMed Central  Google Scholar 

  7. Biss TT, Brandao LR, Kahr WH, et al. Clinical features and outcome of pulmonary embolism in children. Br Jr Hematol. 2008;142:808–18.

    Google Scholar 

  8. Zaidi AU, Hutchins KK, Rajpurkar M. Pulmonary embolism in children. Front Pediatr. 2017;5:170.

    PubMed  PubMed Central  Google Scholar 

  9. Victoria T, Mong A, Altes T, et al. Evaluation of pulmonary embolism in a pediatric population with high clinical suspicion. Pediatr Radiol. 2008;39:35–41.

    PubMed  Google Scholar 

  10. Hedlund GL. Cerebral sinovenous thrombosis in pediatric practice. Pediatr Radiol. 2013;43:173–88.

    PubMed  Google Scholar 

  11. DeVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417–23.

    CAS  PubMed  Google Scholar 

  12. Ichord R. Cerebral sinovenous thrombosis. Front Ped. 2017;5:1–7.

    Google Scholar 

  13. Ichord RN, Benedict SL, Chan AK, et al. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stoke Study. Arch Dis Child. 2014;100:1174–9.

    Google Scholar 

  14. Prisco D, Grifoni E. The role of D-dimer testing in patients with suspected venous thromboembolism. Semin Thromb Hemost. 2009;35:50–9.

    CAS  PubMed  Google Scholar 

  15. Strouse JJ, Tamma P, Kickler TS, et al. D-Dimer for the diagnosis of venous thromboembolism in children. Am J Hematol. 2008;84:62–3.

    Google Scholar 

  16. Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e737S–801S.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Manco-Johnson MJ, Grabowski EF, Hellgreen M, et al. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost. 2002;88:157–8.

    CAS  PubMed  Google Scholar 

  18. Goel R, Vedantham S, Goldenberg NA. Antithrombotic therapies anticoagulation and thrombolysis. Pediatr Clin N Am. 2013;60:1463–74.

    Google Scholar 

  19. Mahajerin A, Betensky M, Goldenberg NA. Thrombosis in children approach to anatomic risks, thrombophilia, prevention, and treatment. Hematol Oncol Clin N Am. 2019;33:439–53.

    Google Scholar 

  20. Tarango C, Manco-Johnson MJ. Pediatric thrombolysis: a practical approach. Front Pediatr. 2017;5:260.

    PubMed  PubMed Central  Google Scholar 

  21. Goldenberg NA, Branchford B, Wang M, et al. Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep venous thrombosis of the proximal limb in adolescents: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol. 2011;22:121–32.

    PubMed  PubMed Central  Google Scholar 

  22. Monagle P, Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program. 2018:399–404.

    Google Scholar 

  23. Kerlin BA. Current and future management of pediatric venous thromboembolism. Am J Hematol. 2012;87:S68–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res. 2006;118:123–35.

    CAS  PubMed  Google Scholar 

  25. Young G, Boshkov LK, Sullivan JE, et al. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study. Pediatr Blood Cancer. 2011;56:1103–9.

    CAS  PubMed  Google Scholar 

  26. O’Brien SH, Yee DL, Lira J, et al. UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis. J Thromb Haemost. 2015;13:1615–22.

    PubMed  Google Scholar 

  27. Hursting MJ, Dubb J, Verme-Gibboney CN. Argatroban anticoagulation in pediatric patients. J Pediatr Hematol Oncol. 2006;28:4–10.

    CAS  PubMed  Google Scholar 

  28. Buck ML. Bivalirudin as an alternative to heparin for anticoagulation in infants and children. J Pediatr Pharmacol Ther. 2015;20:408–17.

    PubMed  PubMed Central  Google Scholar 

  29. Young G. Anticoagulants in children and adolescents. Hematology Am Soc Hematol Educ Program. 2015:111–6.

    Google Scholar 

  30. Punzalan RC, Hillery CA, Montgomery RR, et al. Low-molecular weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol. 2000;22:137–42.

    CAS  PubMed  Google Scholar 

  31. Klassen ILM, Sol JJ, Suijker MH, et al. Are low-molecular weight heparins safe and effective in children? A systematic review. Blood Rev. 2019;33:33–42.

    Google Scholar 

  32. Raffini L, Huang YS, Witmer C, et al. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124:1001–8.

    PubMed  Google Scholar 

  33. Schobess R, During C, Bidlingmaier C, et al. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration. Haematologica. 2006;91:1701–4.

    CAS  PubMed  Google Scholar 

  34. Dabbous MK, Sakr FR, Malaeb DM. Anticoagulant therapy in pediatrics. J Basic Clin Pharm. 2014;5:27–33.

    PubMed  PubMed Central  Google Scholar 

  35. Cohen AT, Bauersachs R. Rivaroxaban and the EINSTEIN clinical trial programme. Blood Coagul Fibrinolysis. 2019;30:85–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Male C, Thom K, O’Brien SH. Direct oral anticoagulants: what will be their role in children? Thromb Res. 2019;173:178–85.

    CAS  PubMed  Google Scholar 

  37. Burnett AE, Mahan CE, Vazquez SR, et al. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb Thrombolysis. 2016;41:206–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Pengo V, Denas G, Zoppellar G, et al. Rivaroxaban vs. warfarin in high-risk patients with antiphospholipid antibody syndrome. Blood. 2018;132:1365–71.

    CAS  PubMed  Google Scholar 

  39. Cuker A, Burnett A, Triller D, et al. Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol. 2019;94:697–709.

    PubMed  Google Scholar 

  40. Tarango C, Schulman S, Betensky M, et al. Duration of anticoagulant therapy in pediatric venous thromboembolism: current approaches and updates from randomized controlled trials. Expert Rev Hematol. 2018;11:37–44.

    CAS  PubMed  Google Scholar 

  41. Van Ommen CH, Nowak-Gottl U. Inherited thrombophilia in pediatric venous thromboembolic disease: why and who to test. Front Pediatr. 2017;5:50.

    PubMed  PubMed Central  Google Scholar 

  42. Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation. 2008;118:1373–82.

    PubMed  Google Scholar 

  43. Wincup C, Ioannou Y. The differences between childhood and adult onset antiphospholipid syndrome. Front Pediatr. 2018;6:362.

    PubMed  PubMed Central  Google Scholar 

  44. Avcin T, Cimaz R, Silverman ED, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008;122:1100–7.

    Google Scholar 

  45. Berkun Y, Padeh S, Barash J, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850–5.

    CAS  PubMed  Google Scholar 

  46. Groot N, de Graeff N, Avcin T, et al. European evidence-based recommendations for the diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis. 2017;76:1637–41.

    CAS  PubMed  Google Scholar 

  47. Monagle P, Newall F. Anticoagulation in children. Thromb Res. 2012;130:142–6.

    CAS  PubMed  Google Scholar 

  48. Boonyawat K, O’Brien SH, Bates SM. How I treat heavy menstrual bleeding associated with anticoagulants. Blood. 2017;130:2603–9.

    CAS  PubMed  Google Scholar 

  49. Goldenberg NA, Donadini MP, Kahn SR. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica. 2010;95:1952–9.

    PubMed  PubMed Central  Google Scholar 

  50. Betensky M, Goldenberg NA. Post-thrombotic syndrome in children. Thromb Res. 2018;164:129–35.

    CAS  PubMed  Google Scholar 

  51. Rajpurkar M, Sharathkumar A, Williams S, et al. Recommendations for the assessment of non-extremity venous thromboembolism outcomes: communication from the SCC of the ISTH. J Thromb Haemost. 2015;13:477–80.

    CAS  PubMed  Google Scholar 

  52. Raffini L, Trimarchi T, Beliveau J, et al. Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative. Pediatrics. 2011;127:1326–32.

    Google Scholar 

  53. Srivaths L, Dietrich JE. Prothrombotic risk factors and preventative strategies in adolescent venous thromboembolism. Clin Appl Thromb Hemost. 2016;22:512–9.

    CAS  PubMed  Google Scholar 

  54. Mahajerin A, Petty JK, Hanson SJ, et al. Prophylaxis against venous thromboembolism in pediatric trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma and the Pediatric Trauma Society. J Trauma Acute Care Surg. 2016;82:627–36.

    Google Scholar 

  55. Lyle CA, Sidonio RF, Goldenberg NA. New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants. Curr Opin Pediatr. 2015;27:18–25.

    CAS  PubMed  Google Scholar 

  56. Biss T, Alikhan R, Payne J, et al. Venous thromboembolism occurring during adolescence. Arch Dis Child. 2016;101:427–32.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology/BMT, Children’s Mercy Kansas City, Kansas City, MO, USA

    Lauren E. Amos

  2. University of Missouri Kansas City, Kansas City, MO, USA

    Mukta Sharma & Shannon L. Carpenter

Authors
  1. Lauren E. Amos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mukta Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shannon L. Carpenter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lauren E. Amos .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA

    Lakshmi V. Srivaths

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Amos, L.E., Sharma, M., Carpenter, S.L. (2020). Diagnosis, Prevention, and Management of Venous Thromboembolism in the Adolescent Female. In: Srivaths, L. (eds) Hematology in the Adolescent Female. Springer, Cham. https://doi.org/10.1007/978-3-030-48446-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48446-0_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48445-3

  • Online ISBN: 978-3-030-48446-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation